Quethera Ltd

Quethera is a gene therapy company dedicated to improving the future treatment of common blinding eye diseases. The initial focus is on developing therapies to reduce progressive visual loss in glaucoma and other conditions affecting the optic nerve. Quethera is working alongside world leaders in the glaucoma field to design clinical trials capable of examining the efficacy and safety of novel therapies in patients who lose parts of their visual field at an accelerated rate (fast-progressors). The company has expertise in gene therapeutic design and development sufficient to progress its pipeline through preclinical testing and into clinical development.

Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology


Associated Team Members

Relevant News

Quethera Announces Seed Financing To Develop Gene Therapy Aimed At Preventing Blindness In Glaucoma Patients

24 September 2015 Quethera, a gene therapy company developing a treatment for glaucoma that could…

read more

Quethera will present pre-clinical efficacy data at the Association for...

Quethera will present pre-clinical efficacy data at the Association for Research in Vision and...

read more

Best glaucoma poster award to Quethera and Cambridge University at...

Quethera and the Cambridge University Department of Clinical Neurosciences awarded the prize for the...

read more

The Welcome Trust – 2016-03-01

Quethera Ltd, a privately funded gene therapy company based at the Babraham Research Campus...

read more

More Companies in Medical / Biotechnology

Your browser is out-of-date!

Update your browser to view this website correctly.Update my browser now